| Literature DB >> 32561815 |
Fotini Kokou1,2,3, Goor Sasson4, Itzhak Mizrahi4, Avner Cnaani5.
Abstract
The constant increase in aquaculture production has led to extensive use of antibiotics as a means to prevent and treat diseases, with adverse implications on the environment, animal health and commensal microbes. Gut microbes are important for the host proper functioning, thus evaluating such impacts is highly crucial. Examining the antibiotic impact on gut segments with different physiological roles may provide insight into their effects on these microhabitats. Hence, we evaluated the effect of feed-administrated antibiotics on the composition and metabolic potential of the gut microbiome in the European seabass, an economically important aquaculture species. We used quantitative PCR to measure bacterial copy numbers, and amplicon sequencing of the 16S rRNA gene to describe the composition along the gut, after 7-days administration of two broad-range antibiotic mixtures at two concentrations. While positive correlation was found between antibiotic concentration and bacterial abundance, we showed a differential effect of antibiotics on the composition along the gut, highlighting distinct impacts on these microbial niches. Moreover, we found an increase in abundance of predicted pathways related to antibiotic-resistance. Overall, we show that a high portion of the European seabass gut microbiome persisted, despite the examined antibiotic intake, indicating high stability to perturbations.Entities:
Mesh:
Substances:
Year: 2020 PMID: 32561815 PMCID: PMC7305304 DOI: 10.1038/s41598-020-66622-5
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.379
Antibiotic mixtures used in the present study.
| Antibiotic Range | Mix 1 | Mix 2 |
|---|---|---|
| Ampicillina | Penicillinb | |
| Kanamycinc | Streptomycind | |
| Erythromycine | Lincomycinf | |
| Ciproflaxineg | ||
| Vancomycinh | ||
aAmpicillin anhydrous, 96.0–100.5% (anhydrous basis), A9393-5G.
bPenicillin G sodium salt, P3032-100MU.
cKanamycin sulfate from Streptomyces kanamyceticus, K4000-5G.
dStreptomycin sulfate salt, S9137-25G.
eE5389-5G.
fLincomycin hydrochloride, L2774-1MU.
g17850-5G-F.
hVancomycin hydrochloride from Streptomyces orientalis, V1130-5G.
Figure 1Number of 16S rRNA gene copy numbers measured with quantitative PCR within each gut compartment of fish fed with different diets (control and antibiotics). Significance was tested with Wilcoxon rank-sum two-sided test at P < 0.05.
Figure 2Shannon H’ diversity of the microbial communities of the different diets (control and antibiotics) in each gut part. Significance was tested with Wilcoxon rank-sum two way test at P < 0.05.
Linear mixed-effects model by restricted maximum likelihood (REML) for gut location and treatment on Shannon diversity and richness.
| d.f. | F | Significant contrasts | ||
|---|---|---|---|---|
| AIC = 158.89, BIC = 200.12, logLik = −61.44 | ||||
| Gut location | 2 | 14.80 | <0.001* | Midgut higher than pyloric and hindgut |
| Treatment | 4 | 0.5606 | 0.06920 | |
| Location: Diet | 8 | 1.5424 | 0.1591 | |
| AIC = 715.91, BIC = 757.13, logLik = −339.95 | ||||
| Gut location | 2 | 12.15 | <0.001* | Midgut higher than pyloric and hindgut |
| Treatment | 4 | 0.51 | 0.7241 | |
| Location: Diet | 8 | 0.71 | 0.6737 | |
*Statistical significance at P < 0.05.
d.f., degrees of freedom; AIC, Akaike information criterion; BIC, Bayesian information criterion; logLik, log of likelihood.
Permanova results for experimental communities based on Bray–Curtis distances.
| d.f. | SS | MS | PseudoF | R2 | ||
|---|---|---|---|---|---|---|
| 4 | 0.27876 | 0.069691 | 2.12540 | 0.09209 | 0.002** | |
| 2 | 0.14271 | 0.071354 | 2.17612 | 0.04714 | 0.011* | |
| 8 | 0.21200 | 0.026500 | 0.80819 | 0.07003 | 0.868 | |
| 73 | 2.39365 | 0.032790 | 0.79073 | |||
| 87 | 3.02712 | 1.00000 |
*, **Statistical significance at P < 0.05 and 0.01, respectively. Permutations n = 999.
d.f., degrees of freedom; SS, sum of squares; MS, mean sum of squares.
Figure 3(A) Microbial composition at the order level across the gut and within each antibiotic-treated group. (B) Bray-Curtis within group similarity across the different gut parts and antibiotic treatments. Stars indicate significance at P < 0.05, after performing Wilcoxon rank-sum two-way test, between the treatments and the control.
Figure 4Pathway enrichment analysis using PICRUSt-predicted KEGG (Kyoto Encyclopaedia of Genes and Genomes) orthologs between the antibiotic-fed groups and the control in the midgut. Significance in pathway enrichment was tested using LEfSe analysis.
Figure 5(A) The persistent microbiome is shared between treatments (left) and gut parts (right), as indicated by the Venn diagram. (B) The relative abundance of the persistent microbiome overall consisted of around 60% of the overall abundance, while it increased with antibiotic resistance, especially observed in the midgut and hindgut. (C) Principal Coordinate Analysis based on Jaccard metric on the antibiotic genes’ richness between the persistent and the affected (non-persistent) microbes. P-value (P = 0.0001) indicates significance based on Permanova (Jaccard metric).